Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03213028
• Date of registration: 03/05/2017
• Prospective Registration: Yes
• Primary sponsor: University of Pennsylvania
• Public title: Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy
• Scientific title: Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy
• Date of first enrolment: August 18, 2017
• Target sample size: 248
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03213028
• Study type: Interventional
• Study design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Botswana

Key inclusion & exclusion criteria

Inclusion Criteria:

1. Female

2. English or Setswana speaking

3. Receiving CCP services at the clinic

4. 18-45 years of age

5. Able to give informed consent to study procedures, as determined by research/clinic
staff

Exclusion Criteria:

1. Pregnant



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Family Planning

Intervention(s)

Other: WHO Decision-Making Tool for Family Planning Clients and Providers

Primary Outcome(s)

Provider acceptability rating [Time Frame: 6 months]

Provider report of adoption of the intervention [Time Frame: 6 months]

Provider rating of feasibility [Time Frame: 6 months]

Secondary ID(s)

823794

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

National Institute of Allergy and Infectious Diseases (NIAID)

University of Botswana